Ron, if CANN gets the approval in place for the S3 OTC product (expected to take most of next year), produces strong research results from their partnership’s such as the Olivia Newton John Foundation and can get a few more products in the pipe line you will see your money. In your position I would personally double down and half your average unit price so you can see profit sooner. I think we are close to seeing market bottom as base assets begin to outstrip share price.
Of course your financial position and risk appetite is different to mine and I fully respect any hesitation to put a cent more into a company that has seen you take a 1500% loss so far.
Good luck for the future!
CAN Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)